Table 4.
Sleep Disturbance Visual Analogue Scale (SD-VAS) of Patients with Sleep Disturbance
| SD N (%) |
SD VAS Scores Mean, Standard Deviation (SD) |
SD VAS Mild (>0 to <3 Points) |
SD VAS Moderate (≥3 to <7 Points) |
SD VAS Severe or Very Severe (≥7 to 10 Points) |
||
|---|---|---|---|---|---|---|
| Cutaneous disorders | Total n=2871 | 2045 (71.2) | 4.13 ± 2.51 | 795 (38.9%) | 919 (44.9%) | 331 (16.9%) |
| Control | Total n=863 | 282 (32.7) | 3.54 ± 2.32 | 132 (46.8% | 128 (45.4%) | 22 (7.8%) |
| Category of patients | Symptomatic n=2689 | 1964 (73) | 4.15 ± 2.51 | 756 (38.5%) | 884 (45%) | 324 (16.5%) |
| Pruritis n=2325 | 1728 (74.3) | 4.14 ± 2.51 | 676 (39.1%) | 769 (44.5%) | 283 (16.4%) | |
| Painn =159 | 115 (72.3) | 4.85 ± 2.55 | 27 (23.5%) | 62 (53.9%) | 26 (22.6%) | |
| Intermediate sensations n=205 | 121 (59) | 3.72 ± 2.42 | 53 (43.8%) | 53 (43.8%) | 15 (12.4%) | |
| Asymptomatic n=182 | 81 (44.5) | 3.56+/2.35 | 39 (48.1%) | 35 (43.2%) | 7 (8.6%) | |
| Type of Skin Disorders | Acnen=1044 | 715 (68.5) | 4.02 ± 2.51 | 282 (39.4%) | 323 (45.2%) | 110 (15.4%) |
| Psoriasis n=163 | 114 (69.9) | 3.92 ± 2.40 | 50 (43.9%) | 50 (43.9%) | 14 (12.3%) | |
| Atopic dermatitis n=254 | 183 (72) | 4.01 ± 2.49 | 77 (42.1%) | 81 (44.3%) | 25 (13.7%) | |
| Contact dermatitis n=147 | 116 (78.9) | 3.90 ± 2.33 | 47 (40.5%) | 56 (48.3%) | 13 (11.2%) | |
| Rosacea n=201 | 139 (69.2) | 4.20+/2.53 | 55 (39.6%) | 61 (43.9%) | 23 (16.5%) | |
| Vitiligo n=50 | 41 (82.0) | 4.59 ± 2.86 | 15 (36.6%) | 16 (39.0%) | 10 (24.4%) | |
| Seborrheic dermatitis n=195 | 139 (71.3) | 4.05 ± 2.47 | 54 (38.8%) | 61 (43.9%) | 24 (17.3%) | |
| Scalp disorders n=216 | 168 (77.8) | 3.97 ± 2.48 | 70 (41.7%) | 76 (45.2%) | 22 (13.1%) | |
| Photodermatosis n=422 | 319 (75.6) | 4.70 ± 2.55 | 97 (30.4%) | 151 (47.3%) | 71 (22.3%) | |
| Others skin disorders n=179 |
111 (62.0) | 3.93 ± 2.44 | 48 (43.2%) | 44 (39.6%) | 19 (17.1%) | |
| Gender | Male n=1306 | 907 (69.4) | 3.84 ± 2.41 | 393 (43.3%) | 401 (44.2%) | 113 (12.5%) |
| Female n=1565 | 1138 (72.7) | 4.36 ± 2.56 | 402 (35.3%) | 518 (45.5%) | 218 (19.2%) | |
| Age | 18–29 years n=903 | 631 (69.9) | 3.98 ± 2.33 | 236 (37.4%) | 313 (49.6%) | 82 (13.0%) |
| 30–39 years n=656 | 463 (70.6) | 3.98 ± 2.40 | 184 (39.7%) | 222 (47.9%) | 57 (12.3%) | |
| 40–49 years n=588 | 453 (77.0) | 4.17 ± 2.58 | 188 (41.5%) | 180 (39.7%) | 85 (18.8%) | |
| 50–59 years n=37 | 263 (69.6) | 4.49 ± 2.81 | 99 (37.6%) | 104 (39.5%) | 60 (22.8%) | |
| >60 years n=346 |
235 (67.9) | 4.35 ± 2.62 | 88 (37.4%) | 100 (42.6%) | 47 (20.0%) |